Teva Pharmaceutical Industries (NYSE: TEVA) plans to acquire privately held Emalex Biosciences in a deal built around Emalex’s lead drug candidate, ecopipam. Teva will pay…
Collaboration overview Helus Pharma (NASDAQ: HELP) announced a partnership with mental‑health platform TARA Mind to support veteran mental health and accelerate recruitment into Helus’ Phase 3 PARADIGM trial…
April 28, 2026
Quoin Pharmaceuticals Expands QRX009 Platform with Multi-Indication Clinical Roadmap for 2026
Quoin Pharmaceuticals (NASDAQ: QNRX) has outlined a clinical and regulatory roadmap that expands the development path for QRX009, its proprietary topical rapamycin platform. The company…
April 27, 2026
Catalyst Pharma Jumps On Reported Takeover Interest
Stock move and headline catalyst Shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) surged after a media report indicated the rare‑disease drug maker has drawn takeover interest from at…
Shares of Hepion Pharmaceuticals, Inc. (OTC: HEPA) are moving higher, with the stock up about 23% today to $0.0503 as very light absolute dollar flows translate into large percentage…
Veradermics hair loss trial update Veradermics’ (NYSE: MANE) lead candidate VDPHL01, an extended‑release oral minoxidil tablet, showed statistically significant hair growth versus placebo in men…
Shares surge on extraordinary volume as CPIX sheds its commercial portfolio to bet on ifetroban Cumberland Pharmaceuticals (NASDAQ: CPIX) is transforming itself overnight. On Thursday,…
Organon ( $OGN) is ripping higher on renewed M&A chatter, after fresh reports that India’s Sun Pharmaceutical Industries is preparing an all‑cash takeover offer that could value the…
Shares of Nuburu, Inc. (NYSE American: BURU) are ripping higher, recently trading at $0.3844, up 36.75% on the day after opening at $0.3215 and touching an intraday high of $0.4399 on volume of more…
April 23, 2026
Biotech Minicaps to AI Agents: Silo Pharma’s Qwikagents Deal Aims at a Multi‑Billion‑Dollar Market
Silo Pharma (NASDAQ: SILO) is jumping into the AI boom, acquiring the Qwikagents.ai platform and launching a dedicated AI subsidiary to target the fast‑growing “AI agent”…
April 22, 2026
AbbVie Bets Big on Durham: $1.4 Billion Campus to Power Its Next Generation of Medicines
AbbVie (NYSE: ABBV) is making a major long‑term bet on North Carolina, committing roughly 1.4 billion dollars to build a new manufacturing campus in Durham that…
Shares of Velo3D, Inc. (Nasdaq: VELO) are ripping higher, trading at $15.59, up 33.59% today after opening at $12.155 and touching an intraday high of $16.10 on volume of 8.86 million shares, well above its 2.20 million average….